Skip to main content
. 2010 Jul 12;42(8):555–564. doi: 10.3858/emm.2010.42.8.056

Figure 3.

Figure 3

Rebamipide suppresses the expression of PLD1 protein in AGS and MKN-1 gastric cancer cells. (A) AGS and MKN-1 cells were treated with the indicated concentrations of rebamipide for 24 h. (B) AGS and MKN-1 cells were treated with rebamipide (5 mM) for the indicated times. The cell lysates were analyzed by western blot using an antibody to PLD. The level of PLD1 expression was determined by densitometer analysis. The data are representative of results obtained from three independent experiments.